{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:50:08Z","timestamp":1788274208397,"version":"build-2803163510"},"reference-count":133,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004071","name":"Khon Kaen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jiph.2026.103267","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:21:11Z","timestamp":1779466871000},"page":"103267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and management of vancomycin non-susceptible Staphylococcus aureus: A narrative review"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4735-5074","authenticated-orcid":false,"given":"Aroonlug","family":"Lulitanond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6849-3820","authenticated-orcid":false,"given":"Aroonwadee","family":"Chanawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2895-3386","authenticated-orcid":false,"given":"Chikara","family":"Kaito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"5219","key":"10.1016\/j.jiph.2026.103267_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","article-title":"Celbenin-resistant staphylococci","volume":"1","author":"Javon","year":"1961","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/cid\/ciab510","article-title":"Pediatric Staphylococcus aureus bacteremia: clinical spectrum and predictors of poor outcome","volume":"74","author":"Campbell","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jiph.2026.103267_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/pathogens13080675","article-title":"The etiology of bloodstream infections at an Italian pediatric tertiary care hospital: A 17-year-long series","volume":"13","author":"Russo","year":"2024","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106264","article-title":"Comparative genome analysis of global and Russian strains of community-acquired methicillin-resistant Staphylococcus aureus ST22, a 'Gaza clone'","volume":"57","author":"Gostev","year":"2021","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5455\/javar.2023.j641","article-title":"Pet animals as reservoirs for spreading methicillin-resistant Staphylococcus aureus to human health","volume":"10","author":"Khairullah","year":"2023","journal-title":"J Adv Vet Anim Res"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1368-7646(03)00003-7","article-title":"Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC","volume":"6","author":"Ito","year":"2003","journal-title":"Drug Resist Updat"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","article-title":"Antibiotic resistance and the MRSA problem","volume":"7","author":"Vestergaard","year":"2019","journal-title":"Microbiol Spectr"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jcpt.12743","article-title":"Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia","volume":"43","author":"Lewis","year":"2018","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"10.1016\/j.jiph.2026.103267_bib10","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/cid\/ciab452","article-title":"Current paradigms of combination therapy in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: does it work, which combination, and for which patients?","volume":"73","author":"Rose","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293423","article-title":"Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: a systematic literature review and meta-analysis","volume":"19","author":"Adamu","year":"2024","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jpids\/piad032","article-title":"Time for a change: considering vancomycin alternatives for pediatric methicillin-resistant Staphylococcus aureus bacteremia","volume":"12","author":"Haynes","year":"2023","journal-title":"J Pediatr Infect Dis Soc"},{"key":"10.1016\/j.jiph.2026.103267_bib13","series-title":"CLSI supplement M100","article-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2024"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib14","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JCM.02302-10","article-title":"Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates","volume":"49","author":"van Hal","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiph.2026.103267_bib16","unstructured":"Centers for Disease Control and Prevention (U.S.). Center for Surveillance, Epidemiology, and Laboratory Services. National notifiable diseases surveillance system. Vancomycin-resistant Staphylococcus aureus: (Week 52) Weekly cases of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 28, 2024. Published Date: 01\/02\/2025. [Cited 2025 August 27]. Available from \u3008https:\/\/stacks.cdc.gov\/view\/cdc\/\u3009."},{"key":"10.1016\/j.jiph.2026.103267_bib17","unstructured":"Clinician Brief: Clinical laboratories' and infection preventionists' roles in the search for and containment of vancomycin-resistant Staphylococcus aureus. [Cited 2025 August 27]. Available from \u3008https:\/\/www.cdc.gov\/staphylococcus-aureus\/hcp\/clinical-overview\/index.html\u3009 Health Care Providers Apr. 15, 2024."},{"key":"10.1016\/j.jiph.2026.103267_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/S0037-86822011005000035","article-title":"Community prevalence of methicillin and vancomycin resistant Staphylococcus aureus in and around Bangalore, southern India","volume":"44","author":"Goud","year":"2011","journal-title":"Rev da Soc Bras De Med Trop"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4103\/0971-5916.91001","article-title":"Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad","volume":"134","author":"Thati","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jiph.2026.103267_bib20","article-title":"Minimum inhibitory concentrations of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolated from various clinical specimens: a study from South India","volume":"12","author":"Moses","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jiph.2026.103267_bib21","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1099\/jmm.0.000566","article-title":"Detection of high levels of resistance to linezolid and vancomycin in Staphylococcus aureus","volume":"66","author":"Azhar","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jiph.2026.103267_bib22","first-page":"1199","article-title":"Frequency and comparison among antibiotic resistant Staphylococcus aureus strains in selected hospitals of Peshawar, Pakistan","volume":"70","author":"Ahmad","year":"2020","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.jiph.2026.103267_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcmj.2014.12.001","article-title":"Prevalence and antimicrobial susceptibility pattern of methicillin-resistant, vancomycin-resistant, and Panton-Valentine leukocidin positive Staphylococcus aureus in a tertiary care hospital Dhaka, Bangladesh","volume":"27","author":"Islam","year":"2015","journal-title":"Tzu Chi Med J"},{"key":"10.1016\/j.jiph.2026.103267_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tcmj.2016.03.002","article-title":"Prevalence of vancomycin-resistant Staphylococcus aureus (VRSA) in methicillin-resistant S. aureus (MRSA) strains isolated from burn wound infections","volume":"28","author":"Hasan","year":"2016","journal-title":"Tzu Chi Med J"},{"key":"10.1016\/j.jiph.2026.103267_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3126\/nepjoph.v2i2.3716","article-title":"Bacteriology and antimicrobial susceptibility of adult chronic dacryocystitis","volume":"2","author":"Chaudhary","year":"2010","journal-title":"Nepal J Ophthalmol"},{"key":"10.1016\/j.jiph.2026.103267_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3847347","article-title":"Molecular confirmation of vancomycin-resistant Staphylococcus aureus with vanA gene from a hospital in Kathmandu","volume":"2021","author":"Maharjan","year":"2021","journal-title":"Int J Microbiol"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/antibiotics11030408","article-title":"Incidence of vancomycin-resistant Staphylococcus aureus strains among patients with urinary tract infections","volume":"11","author":"Selim","year":"2022","journal-title":"Antibiot (Basel)"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.18683\/germs.2018.1140","article-title":"Vancomycin resistance among Staphylococcus aureus isolates in a rural setting, Egypt","volume":"8","author":"ElSayed","year":"2018","journal-title":"Germs"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib29","first-page":"45","article-title":"Detection of vancomycin resistance among hospital and community-acquired methicillin-resistant Staphylococcus aureus isolates","volume":"32","author":"Gohar","year":"2023","journal-title":"Egyp J Med Microbiol"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib30","article-title":"Methicillin and vancomycin-resistant Staphylococcus aureus and associated risk factors among patients with wound infection in East Wallaga Zone, Western Ethiopia","volume":"6","author":"Abebe","year":"2024","journal-title":"Infect Prev Pr"},{"key":"10.1016\/j.jiph.2026.103267_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4038\/cmj.v48i2.3375","article-title":"Staphylococcus aureus with reduced susceptibility to vancomycin","volume":"48","author":"Weerakoon","year":"2003","journal-title":"Ceylon Med J"},{"key":"10.1016\/j.jiph.2026.103267_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jgar.2018.01.017","article-title":"Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran","volume":"14","author":"Ghahremani","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib33","doi-asserted-by":"crossref","DOI":"10.5812\/archcid-132652","article-title":"Phenotypic and molecular characterization of vancomycin and linezolid resistance in clinical isolates of Staphylococcus aureus","volume":"19","author":"Aslanimehr","year":"2024","journal-title":"Arch Clin Infect Dis"},{"key":"10.1016\/j.jiph.2026.103267_bib34","first-page":"316","article-title":"Current status and future prospective of vancomycin-resistant Staphylococcus aureus (VRSA)","volume":"3","author":"Fatima","year":"2023"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/15347346211050771","article-title":"Clinical and microbiological profile of diabetic foot ulcers infected with Staphylococcus aureus in a regional general hospital in Bahia, Brazil","volume":"23","author":"Nascimento","year":"2024","journal-title":"Int J Low Extrem Wounds"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/antibiotics12060972","article-title":"Epidemiology of Staphylococcus aureus non-susceptible to vancomycin in South Asia","volume":"12","author":"Ejaz","year":"2023","journal-title":"Antibiot (Basel)"},{"key":"10.1016\/j.jiph.2026.103267_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jgar.2024.02.002","article-title":"Global distribution of heterogeneous vancomycin-intermediate Staphylococcus aureus strains (1997-2021): a systematic review and meta-analysis","volume":"37","author":"Keikha","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5694\/j.1326-5377.2004.tb06246.x","article-title":"Emergence of heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) infection in Western Australia","volume":"181","author":"Murray","year":"2004","journal-title":"Med J Aust"},{"issue":"9","key":"10.1016\/j.jiph.2026.103267_bib39","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1128\/AAC.00206-09","article-title":"Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China","volume":"53","author":"Sun","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/596629","article-title":"Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia","volume":"199","author":"Maor","year":"2009","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/JCM.00914-10","article-title":"Vancomycin susceptibility trends and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates","volume":"49","author":"Pitz","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiph.2026.103267_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jgar.2016.11.006","article-title":"High frequency of SCCmec type V and agr type I among heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in north India","volume":"8","author":"Singh","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"issue":"12","key":"10.1016\/j.jiph.2026.103267_bib43","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1128\/AAC.48.12.4926-4928.2004","article-title":"Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin","volume":"48","author":"Song","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2026.103267_bib44","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1186\/s12879-024-10047-2","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus clinical isolates: a spectrum of less investigated uncertainties","volume":"24","author":"Tawfeek","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/jac\/dki272","article-title":"Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital","volume":"56","author":"Sancak","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3855\/jidc.12799","article-title":"Investigation of heteroresistant vancomycin intermediate Staphylococcus aureus among MRSA isolates","volume":"15","author":"Gazel","year":"2021","journal-title":"J Infect Dev Ctries"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66118-8","article-title":"Vancomycin heteroresistance (hVISA) in MRSA links to treatment failure and supports a revised PAP-AUC threshold","volume":"16","author":"Fatsis-Kavalopoulos","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/ajprhc.ajprhc_14_21","article-title":"Detection of heteroresistant vancomycin-intermediate Staphylococcus aureus among methicillin-resistant Staphylococcus aureus.","volume":"14","author":"Chaudhary","year":"2022","journal-title":"Asia J Pharma Res Health Care"},{"issue":"7","key":"10.1016\/j.jiph.2026.103267_bib49","article-title":"Prevalence and detection of heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) among clinical isolates: A comparative evaluation of screening methods","volume":"17","author":"Agarwal","year":"2025","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.jiph.2026.103267_bib50","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1128\/JCM.01749-08","article-title":"The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand","volume":"47","author":"Lulitanond","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1128\/JCM.39.2.591-595.2001","article-title":"First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand","volume":"39","author":"Trakulsomboon","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib52","first-page":"S7","article-title":"Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Sanprasitthiprasong Hospital","volume":"97","author":"Panomket","year":"2014","journal-title":"J Med Assoc Thai"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijantimicag.2015.03.009","article-title":"Genotype-specific prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in Asian countries","volume":"46","author":"Chung","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294229","article-title":"Antimicrobial resistance patterns of WHO priority pathogens isolated in hospitalized patients in Japan: a tertiary center observational study","volume":"19","author":"Nisa","year":"2024","journal-title":"PLoS One"},{"issue":"9092","key":"10.1016\/j.jiph.2026.103267_bib55","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(97)07324-8","article-title":"Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin","volume":"350","author":"Hiramatsu","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10156-011-0330-2","article-title":"Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study","volume":"18","author":"Yamakawa","year":"2012","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116180","article-title":"Prevalence and molecular characteristics of heterogeneous vancomycin intermediate Staphylococcus aureus in a tertiary care center of northern China","volume":"108","author":"Cheng","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib58","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jac\/dki486","article-title":"Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20-year study in a large French teaching hospital, 1983-2002","volume":"57","author":"Robert","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib59","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1128\/JCM.41.6.2487-2491.2003","article-title":"High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in the Netherlands","volume":"41","author":"Van Griethuysen","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107154","article-title":"Mechanisms of acquisition of the vanA operon among vancomycin-resistant Staphylococcus aureus genomes: the tip of the iceberg?","volume":"63","author":"Vo","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiph.2026.103267_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1578903","article-title":"Deciphering vancomycin resistance in Enterococcus faecium: gene distribution, sequence typing, and global phylogenetic analysis","volume":"16","author":"Yan","year":"2025","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.jiph.2026.103267_bib62","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/507279","article-title":"Role of horizontal transfer of the transposon Tn1546 in the nosocomial spread of vanA vancomycin-resistant enterococci at a tertiary care hospital in Korea","volume":"27","author":"Yoo","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"43","key":"10.1016\/j.jiph.2026.103267_bib63","doi-asserted-by":"crossref","first-page":"10408","DOI":"10.1021\/bi00107a007","article-title":"Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA","volume":"30","author":"Bugg","year":"1991","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib64","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pro.3819","article-title":"Molecular mechanisms of vancomycin resistance","volume":"29","author":"Stogios","year":"2020","journal-title":"Protein Sci"},{"issue":"8","key":"10.1016\/j.jiph.2026.103267_bib65","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/jb.174.8.2582-2591.1992","article-title":"The VanS\/VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147","volume":"174","author":"Arthur","year":"1992","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jiph.2026.103267_bib66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jgar.2025.01.016","article-title":"Vancomycin-resistant Enterococcus faecium: a current perspective on resilience, adaptation, and the urgent need for novel strategies","volume":"41","author":"Almeida-Santos","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"issue":"10","key":"10.1016\/j.jiph.2026.103267_bib67","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/14787210.2014.956092","article-title":"Mechanisms of antibiotic resistance in enterococci","volume":"12","author":"Miller","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib68","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1089\/mdr.2017.0147","article-title":"Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health","volume":"24","author":"Ahmed","year":"2018","journal-title":"Micro Drug Resist"},{"issue":"36","key":"10.1016\/j.jiph.2026.103267_bib69","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.36.2100767","article-title":"Novel vancomycin resistance gene cluster in Enterococcus faecium ST1486, Belgium, June 2021","volume":"26","author":"Xavier","year":"2021","journal-title":"Eur Surveill"},{"issue":"45","key":"10.1016\/j.jiph.2026.103267_bib70","doi-asserted-by":"crossref","first-page":"37583","DOI":"10.1074\/jbc.M112.405522","article-title":"Structural and functional characterization of VanG D-Ala:D-ser ligase associated with vancomycin resistance in Enterococcus faecalis","volume":"287","author":"Meziane-Cherif","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jiph.2026.103267_bib71","doi-asserted-by":"crossref","DOI":"10.1177\/11786361231183675","article-title":"Genotypically confirmed vancomycin-resistant Staphylococcus aureus with vanB gene among clinical isolates in Kathmandu","volume":"16","author":"Nepal","year":"2023","journal-title":"Microbiol Insights"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.25259\/ijmr_2224_22","article-title":"Presence of multiple van genes among glycopeptide non-susceptible Staphylococcus aureus exhibiting in vitro MIC creep phenomenon: a study from north-east India","volume":"160","author":"Hazarika","year":"2024","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib73","doi-asserted-by":"crossref","DOI":"10.5812\/archcid-132652","article-title":"Phenotypic and molecular characterization of vancomycin and linezolid resistance in clinical isolates of Staphylococcus aureus","volume":"19","author":"Aslanimehr","year":"2024","journal-title":"Arch Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib74","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.diagmicrobio.2016.09.011","article-title":"Phenotypic characteristics and comparative proteomics of Staphylococcus aureus strains with different vancomycin-resistance levels","volume":"86","author":"Sirichoat","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.41.1.5-14.2003","article-title":"Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.","volume":"41","author":"Cui","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiph.2026.103267_bib76","doi-asserted-by":"crossref","first-page":"30823","DOI":"10.1038\/srep30823","article-title":"Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system","volume":"6","author":"Cameron","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jgar.2014.04.006","article-title":"Vancomycin-intermediate resistance in Staphylococcus aureus.","volume":"2","author":"Hiramatsu","year":"2014","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib78","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/AAC.01173-08","article-title":"Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.","volume":"53","author":"Cui","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib79","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12275-013-3088-7","article-title":"Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus","volume":"51","author":"Yoo","year":"2013","journal-title":"J Microbiol"},{"key":"10.1016\/j.jiph.2026.103267_bib80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/bs.ampbs.2024.04.006","article-title":"Staphylococcus aureus response and adaptation to vancomycin","volume":"85","author":"Fait","year":"2024","journal-title":"Adv Micro Physiol"},{"key":"10.1016\/j.jiph.2026.103267_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1241995","article-title":"Teicoplanin associated gene tcaA inactivation increases persister cell formation in Staphylococcus aureus","volume":"14","author":"Habib","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiph.2026.103267_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127635","article-title":"Sub-MIC vancomycin enhances the antibiotic tolerance of vancomycin-intermediate Staphylococcus aureus through downregulation of protein succinylation","volume":"282","author":"Yang","year":"2024","journal-title":"Microbiol Res"},{"issue":"9","key":"10.1016\/j.jiph.2026.103267_bib83","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/AAC.00398-11","article-title":"Mutation of RNA polymerase \u03b2 subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3","volume":"55","author":"Matsuo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib84","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00339-24","article-title":"Metabolic remodeling by RNA polymerase gene mutations is associated with reduced \u03b2-lactam susceptibility in oxacillin-susceptible MRSA","volume":"15","author":"Watanabe","year":"2024","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","article-title":"Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications","volume":"23","author":"Howden","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiph.2026.103267_bib86","unstructured":"Centers for Disease Control and Prevention (CDC). Laboratory testing for vancomycin-resistant Staphylococcus aureus. [Cited 2025 August 31]. Available from \u3008https:\/\/www.cdc.gov\/staphylococcus-aureus\/php\/laboratories\/index.html#cdc_lab_testing_procedures_resources-resources\u3009."},{"issue":"10","key":"10.1016\/j.jiph.2026.103267_bib87","first-page":"1","article-title":"Methicillin resistant Staphylococcus aureus: inconsistencies in vancomycin susceptibility testing methods, limitations and advantages of each method","volume":"9","author":"Himani","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"7","key":"10.1016\/j.jiph.2026.103267_bib88","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1128\/JCM.00221-09","article-title":"Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus","volume":"47","author":"Swenson","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib89","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3343\/alm.2023.43.4.355","article-title":"Development of a single-nucleotide polymorphism genotyping assay for the rapid detection of vancomycin-intermediate resistance in Staphylococcus aureus epidemic lineage ST5","volume":"43","author":"Kim","year":"2023","journal-title":"Ann Lab Med"},{"issue":"9","key":"10.1016\/j.jiph.2026.103267_bib90","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1128\/AAC.02470-13","article-title":"\"Slow VISA,\" a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3","volume":"58","author":"Saito","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2026.103267_bib91","first-page":"399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"47","author":"Wootton","year":"2001"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib92","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jac\/47.3.357","article-title":"Detection of glycopeptide resistance in Staphylococcus aureus","volume":"47","author":"Walsh","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jiph.2026.103267_bib93","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1128\/JCM.01152-11","article-title":"Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States","volume":"49","author":"Richter","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.jiph.2026.103267_bib94","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1007\/s00284-020-02123-y","article-title":"Etest methods for screening heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) strains","volume":"77","author":"Lee","year":"2020","journal-title":"Curr Microbiol"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib95","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s15010-023-02036-5","article-title":"Decrease in vancomycin MICs and prevalence of hGISA in MRSA and MSSA isolates from a German pediatric tertiary care center","volume":"51","author":"Haas","year":"2023","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib96","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/antibiotics13040298","article-title":"Detection of vancomycin resistance among methicillin-resistant Staphylococcus aureus strains recovered from children with invasive diseases in a reference pediatric hospital","volume":"13","author":"Pardo","year":"2024","journal-title":"Antibiot (Basel)"},{"issue":"8","key":"10.1016\/j.jiph.2026.103267_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012422","article-title":"Vancomycin-resistant Staphylococcus aureus (VRSA) can overcome the cost of antibiotic resistance and may threaten vancomycin's clinical durability","volume":"20","author":"Blechman","year":"2024","journal-title":"PLoS Pathog"},{"issue":"10","key":"10.1016\/j.jiph.2026.103267_bib98","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1128\/AAC.00757-12","article-title":"Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia","volume":"56","author":"Han","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib99","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1086\/346207","article-title":"Vancomycin-intermediate Staphylococcus aureus Epidemiology Study Group. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001","volume":"36","author":"Fridkin","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jiph.2026.103267_bib100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jiph.2026.103267_bib101","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00333-24","article-title":"Risk factors for vancomycin treatment failure in heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia","volume":"12","author":"Yun","year":"2024","journal-title":"Microbiol Spectr"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib102","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1128\/AAC.04765-14","article-title":"Clinical and microbiologic analysis of the risk factors for mortality in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bacteremia","volume":"59","author":"Chong","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib103","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"38","author":"Charles","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib104","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/596629","article-title":"Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia","volume":"199","author":"Maor","year":"2009","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jmii.2012.05.004","article-title":"Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center","volume":"45","author":"Lin","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib106","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-015-0763-0","article-title":"Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature","volume":"43","author":"Baxi","year":"2015","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib107","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.22207\/JPAM.16.3.44","article-title":"Linezolid-resistance Staphylococcus aureus \u2013 prevalence, emerging resistance mechanisms, challenges and perspectives","volume":"16","author":"Rafique","year":"2022","journal-title":"J Pure Appl Microbiol"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0732-8893(02)00511-4","article-title":"Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization","volume":"45","author":"Andrade-Baiocchi","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib109","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jac\/dki486","article-title":"Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20-year study in a large French teaching hospital, 1983-2002","volume":"57","author":"Robert","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.jiph.2026.103267_bib110","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1248\/bpb.b20-00217","article-title":"Evaluation of daptomycin-induced cellular membrane injury in skeletal muscle","volume":"43","author":"Yamada","year":"2020","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1183\/09031936.00145014","article-title":"Linezolid to treat MDR-\/XDR-tuberculosis: available evidence and future scenarios","volume":"45","author":"Sotgiu","year":"2015","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib112","first-page":"352","article-title":"Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey","volume":"46","author":"Cesur","year":"2012","journal-title":"Mikrobiyol Bul"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib113","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11908-999-0062-y","article-title":"Quinupristin-Dalfopristin","volume":"1","author":"Linden","year":"1999","journal-title":"Curr Infect Dis Rep"},{"issue":"3","key":"10.1016\/j.jiph.2026.103267_bib114","first-page":"882","article-title":"Trimethoprim\/sulfamethoxazole versus vancomycin in the treatment of healthcare\/ventilator-associated MRSA pneumonia: a case\u2013control study","volume":"72","author":"Eliakim-Raz","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0323935","article-title":"Sulfamethoxazole-trimethoprim plus rifampicin combination therapy for methicillin- resistant Staphylococcus aureus infection: an in vitro study","volume":"20","author":"Nakamura","year":"2025","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib116","doi-asserted-by":"crossref","first-page":"e01743","DOI":"10.1128\/AAC.01743-18","article-title":"Dalbavancin alone and in combination with ceftaroline against four different phenotypes of Staphylococcus aureus in a simulated pharmacodynamic\/pharmacokinetic model","volume":"63","author":"Kebriaei","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2026.103267_bib117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.5414\/ALX02189E","article-title":"Descriptive analysis of adverse drug reaction reports for hypersensitivity reactions stratified in relation to different \u03b2-lactam antibiotics","volume":"6","author":"Dubrall","year":"2022","journal-title":"Allergol Sel"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib118","article-title":"Management and implications of \u03b2-lactam allergies","volume":"16","author":"Zavaleta-Monestel","year":"2024","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib119","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ja.2017.7","article-title":"Synergistic effects of vancomycin and \u03b2-lactams against vancomycin highly resistant Staphylococcus aureus","volume":"70","author":"Tabuchi","year":"2017","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.jiph.2026.103267_bib120","article-title":"Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA","volume":"7","author":"Lai","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib121","doi-asserted-by":"crossref","first-page":"e00157","DOI":"10.1128\/AAC.00157-18","article-title":"\u03b2-lactam combinations with vancomycin show synergistic activity against vancomycin-susceptible Staphylococcus aureus, vancomycin-intermediate S. aureus (VISA), and heterogeneous VISA","volume":"62","author":"Tran","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jiph.2026.103267_bib122","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/antibiotics8040184","article-title":"The potential role of sulbactam and cephalosporins plus daptomycin against daptomycin-nonsusceptible VISA and h-VISA isolates: an in vitro study","volume":"8","author":"Lai","year":"2019","journal-title":"Antibiot (Basel)"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib123","doi-asserted-by":"crossref","first-page":"e02100","DOI":"10.1128\/AAC.02100-17","article-title":"Combination antibiotic exposure selectively alters the development of vancomycin intermediate resistance in Staphylococcus aureus","volume":"62","author":"Zheng","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2026.103267_bib124","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jgar.2021.11.004","article-title":"Successful treatment with daptomycin and ceftaroline of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) endocarditis: a case report","volume":"27","author":"Lin","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40801-024-00422-5","article-title":"Ceftaroline fosamil for the treatment of methicillin-resistant Staphylococcus aureus bacteremia: a real-world comparative clinical outcomes study","volume":"11","author":"Hammond","year":"2024","journal-title":"Drugs Real World Outcomes"},{"issue":"5","key":"10.1016\/j.jiph.2026.103267_bib126","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3201\/eid2505.181773","article-title":"Age-dependent increase in incidence of Staphylococcus aureus bacteremia, Denmark, 2008-2015","volume":"25","author":"Thorlacius-Ussing","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.jiph.2026.103267_bib127","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archinte.159.11.1244","article-title":"Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality","volume":"159","author":"McClelland","year":"1999","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib128","doi-asserted-by":"crossref","first-page":"e606","DOI":"10.1016\/S2666-5247(24)00040-5","article-title":"Staphylococcus aureus colonization and strategies for decolonization","volume":"5","author":"Piewngam","year":"2024","journal-title":"Lancet Microbe"},{"issue":"6","key":"10.1016\/j.jiph.2026.103267_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107005","article-title":"Serum concentration of continuously administered vancomycin influences efficacy and safety in critically ill adults: a systematic review","volume":"62","author":"Viertel","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jiph.2026.103267_bib130","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1186\/s12879-025-11820-7","article-title":"Evaluation of vancomycin utilization in medical and pediatric wards: a retrospective cross-sectional study at Bule Hora University Teaching Hospital, Ethiopia","volume":"25","author":"Gerina","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiph.2026.103267_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101147","article-title":"Mechanism of staphylococcal resistance to clinically relevant antibiotics","volume":"77","author":"Brdov\u00e1","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jiph.2026.103267_bib132","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.3389\/fmicb.2018.02393","article-title":"Rapid Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus based on Matrix-Assisted Laser Desorption Ionization Time-of-Flight: using a machine learning approach and unbiased validation","volume":"9","author":"Wang","year":"2018","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.jiph.2026.103267_bib133","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11274-019-2788-5","article-title":"Attenuated total reflection: fourier transform infrared spectroscopy for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"36","author":"Wongthong","year":"2020","journal-title":"World J Microbiol Biotechnol"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126001395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034126001395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:09:32Z","timestamp":1781698172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034126001395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":133,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1876034126001395"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103267","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and management of vancomycin non-susceptible Staphylococcus aureus: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2026.103267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"103267"}}